Total and lipid-bound serum sialic acid in benign and malignant breast disease

Anticancer Research

Volumn 17, Issue 2B, 1997, Pages 1249-1254

  Romppanen, Jarkko ^a   Eskelinen, Matti ^a   Tikanoja, Sari ^b   Mononen, Ilkka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Medix Biochemica ^*  (Finland)

Author keywords

Breast cancer; Lipid bound sialic acid; Receiver operating characteristic analysis; Sialic acid; Tumor markers

Indexed keywords

LIPID; PROTEIN; SIALIC ACID;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST DISEASE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; BREAST DISEASES; BREAST NEOPLASMS; CHILD; FEMALE; HUMANS; LIPID METABOLISM; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; SENSITIVITY AND SPECIFICITY;

EID: 0030995238     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yogeeswaran G: Cell surface glycolipids and glycoproteins in malignant transformation. Adv Cancer Res 38: 289-350, 1983.
2. Topuz E, Töre G, Bilge N, Aldemir O, Kural N, Kinay M, Güzel Ö: Neuraminsaure (NANA) im serum als indikator beim mamma-karzinorn. Strahlerither Onkol 162: 187-190, 1986.
3. Hogan-Ryan A, Fennelly JJ, Jones M, Cantwell B, Duffy MJ: Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer 41: 587-592, 1980.
4. Plucinsky MC, Riley WM, Prorok JJ, Alhadeff JA: Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 58: 2680-2685, 1986.
5. Shamberger RJ: Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem 22: 647-651, 1984.
6. Schutter EMJ, Visser JJ, van Kamp GJ, Mensdorff-Pouilly S, van Dijk W, Hilgers J, Kenemans P: The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol 13: 121-132, 1992.
7. Patel PS, Baxi BR, Adhvaryu SG, Balar DB: Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res 10: 1071 -1074, 1990.
8. Patel PS, Baxi BR, Adhvaryu SG, Balar DB: Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma. Cancer Lett 51: 203-208, 1990.
9. Silver HKB, Karim KA: High-performance liquid chromatography quantitation of N-acetylneuraminic acid in malignant melanoma and breast carcinoma. J Chromatogr 224: 381-388, 1981.
10. Shukla AK, Schauer R: Analysis of N,O-acylated neuraminic acids by high-performance liquid anion-exchange chromatography. J Chromatogr 244: 81-89, 1982.
11. Katopodis N, Stock CC: Improved method to determine lipid bound sialic acid in plasma or serum. Res Commun Chem Pathol Pharmacol 30: 171-180, 1980.